HomeCompareAIMH vs MRK

AIMH vs MRK: Dividend Comparison 2026

AIMH yields 6896.55% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AIMH wins by $1432605808592863.25M in total portfolio value
10 years
AIMH
AIMH
● Live price
6896.55%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1432605808592863.25M
Annual income
$1,392,875,843,310,163,600,000.00
Full AIMH calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — AIMH vs MRK

📍 AIMH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAIMHMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AIMH + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AIMH pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIMH
Annual income on $10K today (after 15% tax)
$586,206.90/yr
After 10yr DRIP, annual income (after tax)
$1,183,944,466,813,639,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, AIMH beats the other by $1,183,944,466,813,639,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIMH + MRK for your $10,000?

AIMH: 50%MRK: 50%
100% MRK50/50100% AIMH
Portfolio after 10yr
$716302904296431.63M
Annual income
$696,437,921,655,081,800,000.00/yr
Blended yield
97.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AIMH
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIMH buys
0
MRK buys
0
No recent congressional trades found for AIMH or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAIMHMRK
Forward yield6896.55%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$1432605808592863.25M$30.7K
Annual income after 10y$1,392,875,843,310,163,600,000.00$950.29
Total dividends collected$1429942114786334.00M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AIMH vs MRK ($10,000, DRIP)

YearAIMH PortfolioAIMH Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$700,355$689,655.17$11,192$351.54+$689.2KAIMH
2$45,889,900$45,140,520.30$12,524$392.70+$45.88MAIMH
3$2,813,379,172$2,764,276,978.38$14,015$438.65+$2813.37MAIMH
4$161,393,449,836$158,383,134,122.24$15,682$489.96+$161393.43MAIMH
5$8,664,159,276,546$8,491,468,285,221.65$17,547$547.23+$8664159.26MAIMH
6$435,300,017,392,982$426,029,366,967,078.00$19,632$611.16+$435300017.37MAIMH
7$20,469,824,923,231,620$20,004,053,904,621,130.00$21,963$682.53+$20469824923.21MAIMH
8$901,046,035,934,427,400$879,143,323,266,569,700.00$24,571$762.18+$901046035934.40MAIMH
9$37,130,808,675,420,410,000$36,166,689,416,970,576,000.00$27,486$851.08+$37130808675420.39MAIMH
10$1,432,605,808,592,863,400,000$1,392,875,843,310,163,600,000.00$30,745$950.29+$1432605808592863.25MAIMH

AIMH vs MRK: Complete Analysis 2026

AIMHStock

Aimrite Holdings Corporation provides management advisory and consulting services for small and medium size companies. Its services include operational services in corporate development; restructuring, finance, and strategic growth plans, as well as strategic consulting in business planning and sales strategy development; Website consulting and development; and social media development and deployment. The company is based in Las Vegas, Nevada.

Full AIMH Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this AIMH vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIMH vs SCHDAIMH vs JEPIAIMH vs OAIMH vs KOAIMH vs MAINAIMH vs JNJAIMH vs ABBVAIMH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.